Sara Pollan, PhD
Level III Scientist and Scientific Supervisor, NeoGenomics
Date: 19 January 2021
Time: New York 11:00 | Paris 17:00 | London 16:00 | Singapore 00:00 (20 Jan) | Tokyo 01:00 (20 Jan) | Sydney 03:00 (20 Jan)
Duration: 45 minutes
Event structure: Event structure is 30-minute presentation & 15-minutes Q&A.
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 2 February 2021 (registration is required)
Dr. Pollan is a Lead Scientist within the Multiplexed Immunofluorescence (mIF) team with the Pharma Services division at NeoGenomics. Her work focuses on successful optimization and validation of custom multiplex IF panels using the Vectra Polaris platform. She earned her Ph.D. in Translational Medicine at Cedars-Sinai Medical Center and Masters in Biomedical Science at UC Irvine. Dr. Pollan has been featured in the journal Oncogene for discovering a new mechanism used by circulating tumor cells to evade immune detection.